CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study-Reference-Cited by-同舟云学术

CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study

Published:2011 Issue:4 Volume:13 Page:R133
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Rodríguez-Rodríguez Luis,González-Juanatey Carlos,García-Bermúdez Mercedes,Vázquez-Rodríguez Tomas R,Miranda-Filloy Jose A,Fernández-Gutiérrez Benjamin,Llorca Javier,Martin Javier,González-Gay Miguel A

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference28 articles.

1. MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells

2. Human Vascular Smooth Muscle Cells Possess Functional CCR5

3. Chemokine receptor CCR5: insights into structure, function, and regulation

4. CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection

5. Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis;Rheumatology International;2024-03-24

2. Correlation between genetic polymorphisms in apolipoprotein E and atrial fibrillation;Revista Portuguesa de Cardiologia;2022-05

3. Rheumatoid arthritis: Extra-articular manifestations and comorbidities;Autoimmunity Reviews;2021-04

4. Chemokines: A Potential Therapeutic Target to Suppress Autoimmune Arthritis;Current Pharmaceutical Design;2019-10-09

5. Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study;Open Forum Infectious Diseases;2019-03-07